IP Library › Assignment 040647/0908
Patent Assignment
Reel/Frame 040647/0908

General Conveyance and Assumption Agreement

Recorded: 2016-11-18 Pages: 5
Assignor
RVX THERAPEUTICS INC.
Executed: 2014-05-01
Assignee
ZENITH EPIGENETICS CORP.
300,4820 RICHARD ROAD SW, CALGARY, AB, T3E 6L1, CANADA
Covered Property (1)
Novel Bicyclic Bromodomain Inhibitors
Patent: 9,663,520 →
Application: 14/977,508 →
Publication: US 2016/0159801
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 18, 2016
From: QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; LIU, SHUANG; WANG, RUIFANG
To: RVX THERAPEUTICS INC.
Reel/Frame 040371/0901 →
Assignment of Assignor's Interest Nov 18, 2016
From: QUINN, JOHN FREDERICK; WAGNER, GREGORY STEVEN; DUFFY, BRYAN CORDELL; LIU, SHUANG
To: ZENITH EPIGENETICS CORP.
Reel/Frame 040652/0495 →
Change of Name Dec 21, 2016
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 041120/0548 →
Assignment of Assignor's Interest Dec 23, 2016
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 041182/0891 →